Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €35.05 EUR
Change Today -0.05 / -0.14%
Volume 925.0
ALGBE On Other Exchanges
Symbol
Exchange
EN Paris
As of 11:35 AM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

global bioenergies sa (ALGBE) Snapshot

Open
€35.10
Previous Close
€35.10
Day High
€35.10
Day Low
€34.92
52 Week High
06/3/14 - €44.34
52 Week Low
12/29/14 - €25.74
Market Cap
96.9M
Average Volume 10 Days
820.4
EPS TTM
--
Shares Outstanding
2.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GLOBAL BIOENERGIES SA (ALGBE)

Related News

No related news articles were found.

global bioenergies sa (ALGBE) Related Businessweek News

No Related Businessweek News Found

global bioenergies sa (ALGBE) Details

Global Bioenergies produces and sells isobutene. The company’s isobutene products are petrochemical building blocks that can be converted into fuels, plastics, organic glass, and elastomers. Its product applications include olefins markets, markets targeted by bio-processes, and bio fuels. Global Bioenergies was founded in 2008 and is based in Evry, France.

68 Employees
Last Reported Date: 04/9/15
Founded in 2008

global bioenergies sa (ALGBE) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

global bioenergies sa (ALGBE) Key Developments

Global Bioenergies Announces Unaudited Consolidated Earnings Results for the Year Ended December 31, 2014

Global Bioenergies announced unaudited consolidated earnings results for the year ended December 31, 2014. For the year, the company announced operating income of EUR 3,166,000 compared to EUR 1,179,000 for the same period a year ago. Operating loss was EUR 9,500,000 compared to EUR 6,706,000 for the same period a year ago. Net loss was EUR 7,578,000 compared to EUR 5,211,000 for the same period a year ago. The strong increase in operating income results from the simultaneous rise in revenue from collaborative projects with industrial partners, and from French and German grants. Operating cash-flow used was EUR 8,009,000 compared to EUR 4,333,000 for the same period a year ago.

Global Bioenergies Obtains EUR 4.4 Million Loan from a Consortium of Four French Banks to Complete the Financing of its Demo Plant

Global Bioenergies announced having obtained a EUR 4.4 million loan from a consortium of four French banks to complete the financing of its demo plant. The construction phase begins on March 31, 205 and will last one year. These past two years have seen Global Bioenergies focusing on scaling up its bio-production process to isobutene. A first phase has consisted in the construction of an industrial pilot on the agro-industrial site of Pomacle-Bazancourt. Successful start-up was achieved in 2014 and the pilot is now fully operational. The following phase consists in the installation of a demo plant on the petrochemical site of Leuna, near Leipzig in Germany. Global Bioenergies has recently announced having received the corresponding engineering package. The company announced the launch of the demo plant's construction alongside the reception of a EUR 4.4 million loan reimbursable over 5 years. This loan has been secured from a consortium composed of BNP Paribas, Société Générale, CIC and Bpifrance. It is covered by guarantee funds of the Ile-de-France Region managed by Bpifrance. This new financing will cover the purchase of a complete fermentation unit, comprising an inoculation fermenter, a propagation fermenter, and a 5,000L production fermenter. Each are fully instrumented and surrounded by satellite vessels. This unique installation has been specifically designed for the production of gaseous hydrocarbons. It will be installed on the Fraunhofer CBP site within the Leuna refinery. The demo plant's operation will begin in 2016 under the supervision of Global Bioenergies GmbH, a Leipzig-based, 100%-owned subsidiary of Global Bioenergies SA. The demo plant's financing is also supported by a EUR 5.7 million subsidy granted end 2013 by the German Ministry for Education and Research (BMBF). Most of this subsidy is still to be received.

Global Bioenergies Presents at CF&B European Small Cap Event, Apr-27-2015

Global Bioenergies Presents at CF&B European Small Cap Event, Apr-27-2015 . Venue: Paris, France.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALGBE:FP €35.05 EUR -0.05

ALGBE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gevo Inc $2.46 USD -0.05
View Industry Companies
 

Industry Analysis

ALGBE

Industry Average

Valuation ALGBE Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 22.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLOBAL BIOENERGIES SA, please visit www.global-bioenergies.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.